Product Information
VERAPAMIL ER 120 MG TABLET is a generic product labeled by Glenmark Pharmaceuticals Inc., USA, priced at $0.1803 per EA under NDC 68462029201. Its NADAC has been published 665 times since Nov 28, 2013.
FDA first approved this application on Aug 3, 2011. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
120 mg/1
Manufacturer
Glenmark Pharmaceuticals Inc., USANDC
68462029201
Classification
Generic
Dosage Form
TABLET, FILM COATED, EXTENDED RELEASE
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
VERAPAMIL HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA090700FDA Approved
8/3/2011
TE Code
AB
On Market Since
8/5/2011
Pharmacological Classes
Price Statistics
The NADAC for VERAPAMIL ER 120 MG TABLET has been published 665 times since Nov 28, 2013, and over the history we have for it it has declined 26.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1803 per EA |
|---|---|
| All-time high | $0.3647 (Jun 16, 2021) |
| All-time low | $0.1442 (Dec 19, 2018) |
| 52-week high | $0.2492 |
| 52-week low | $0.1803 |
| Median price | $0.2263 |
| Average price | $0.2339 |
| Largest weekly change | +29.2% (Feb 21, 2024) |
| Weeks tracked | 665 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the verapamil hydrochloride market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of VERAPAMIL ER 120 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for VERAPAMIL ER 120 MG TABLET, manufactured by Glenmark Pharmaceuticals Inc., USA, is $0.1803 per EA (NDC 68462029201), effective Aug 19, 2026.
How has the price of VERAPAMIL ER 120 MG TABLET changed over time?
Over the history we have for it, the NADAC for VERAPAMIL ER 120 MG TABLET has declined 26.8%. It has been tracked across 665 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for VERAPAMIL ER 120 MG TABLET?
Since Nov 28, 2013, the NADAC for VERAPAMIL ER 120 MG TABLET has ranged from a low of $0.1442 (Dec 19, 2018) to a high of $0.3647 (Jun 16, 2021), with a median of $0.2263 per EA.
Are there cheaper alternatives to VERAPAMIL ER 120 MG TABLET?
No other NADAC-published product currently shares the active ingredient and strength of VERAPAMIL ER 120 MG TABLET in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures VERAPAMIL ER 120 MG TABLET?
VERAPAMIL ER 120 MG TABLET (NDC 68462029201) is labeled by Glenmark Pharmaceuticals Inc., USA, and CMS classifies it as a generic product.